Published in J Biol Chem on July 30, 2008
RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med (2009) 2.56
Advanced glycation end product recognition by the receptor for AGEs. Structure (2011) 1.84
Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med (Berl) (2009) 1.51
Structural basis for ligand recognition and activation of RAGE. Structure (2010) 1.50
Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep (2011) 1.28
Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol (2010) 1.22
S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem (2011) 1.22
Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. J Biol Chem (2010) 1.19
The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J Biol Chem (2010) 1.16
Role of advanced glycation end products in cardiovascular disease. World J Cardiol (2012) 1.13
Stable RAGE-heparan sulfate complexes are essential for signal transduction. ACS Chem Biol (2013) 1.07
Carboxylated N-glycans on RAGE promote S100A12 binding and signaling. J Cell Biochem (2010) 1.05
Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res (2009) 1.05
Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J Biol Chem (2011) 1.04
RAGE: a new frontier in chronic airways disease. Br J Pharmacol (2012) 1.04
Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. BMC Biochem (2009) 1.03
The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry (2014) 1.02
Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent manner. J Biol Chem (2011) 1.01
S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond. Cardiovasc Psychiatry Neurol (2010) 0.99
Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids (2010) 0.98
APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner. J Bone Miner Res (2011) 0.94
The receptor for advanced glycation end-products (RAGE) is only present in mammals, and belongs to a family of cell adhesion molecules (CAMs). PLoS One (2014) 0.93
Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchange. PLoS One (2013) 0.91
Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea. PLoS One (2011) 0.90
Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics. Amino Acids (2010) 0.90
N(ϵ) -Carboxymethyllysine Increases the Expression of miR-103/143 and Enhances Lipid Accumulation in 3T3-L1 Cells. J Cell Biochem (2016) 0.89
A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE). Redox Biol (2016) 0.89
Solution structure of the soluble receptor for advanced glycation end products (sRAGE). J Biol Chem (2011) 0.87
The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type rage with the G82S polymorphic variant. J Biol Chem (2011) 0.87
S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration. PLoS One (2012) 0.87
The S100B/RAGE Axis in Alzheimer's Disease. Cardiovasc Psychiatry Neurol (2010) 0.86
Is RAGE still a therapeutic target for Alzheimer's disease? Future Med Chem (2012) 0.86
Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis. PLoS One (2012) 0.83
Diabetes and cancer: Looking at the multiligand/RAGE axis. World J Diabetes (2011) 0.83
Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 0.81
Identifying key juxtamembrane interactions in cell membranes using AraC-based transcriptional reporter assay (AraTM). J Biol Chem (2012) 0.81
Combinatorial library of improved peptide aptamers, CLIPs to inhibit RAGE signal transduction in mammalian cells. PLoS One (2013) 0.81
Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iran J Med Sci (2011) 0.80
Structural insights into calcium-bound S100P and the V domain of the RAGE complex. PLoS One (2014) 0.80
Expression and function of psoriasin (S100A7) and koebnerisin (S100A15) in the brain. Infect Immun (2013) 0.77
Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex. Acta Crystallogr D Biol Crystallogr (2015) 0.77
Oriented immobilization of His-tagged protein on a redox active thiol derivative of DPTA-Cu(II) layer deposited on a gold electrode--the base of electrochemical biosensors. Sensors (Basel) (2013) 0.77
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol (2016) 0.77
The STINT-NMR method for studying in-cell protein-protein interactions. Curr Protoc Protein Sci (2010) 0.76
Voltammetric detection of S100B protein using His-tagged receptor domains for advanced glycation end products (RAGE) immobilized onto a gold electrode surface. Sensors (Basel) (2014) 0.76
Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling. Structure (2016) 0.76
AGE-RAGE interaction in the TGFβ2-mediated epithelial to mesenchymal transition of human lens epithelial cells. Glycoconj J (2016) 0.75
Role of the advanced glycation end products receptor in Crohn's disease inflammation. World J Gastroenterol (2013) 0.75
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective. J Med Chem (2017) 0.75
Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury. Sci Rep (2017) 0.75
Mapping structural interactions using in-cell NMR spectroscopy (STINT-NMR). Nat Methods (2006) 2.15
Advanced glycation end product recognition by the receptor for AGEs. Structure (2011) 1.84
Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol (2007) 1.74
PRMT7, a new protein arginine methyltransferase that synthesizes symmetric dimethylarginine. J Biol Chem (2004) 1.63
Glycerol-3-phosphate dehydrogenase 2 is a novel factor H-, factor H-like protein 1-, and plasminogen-binding surface protein of Candida albicans. J Infect Dis (2012) 1.58
FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. Biochem Biophys Res Commun (2006) 1.54
Semisynthesis of a segmental isotopically labeled protein splicing precursor: NMR evidence for an unusual peptide bond at the N-extein-intein junction. Proc Natl Acad Sci U S A (2004) 1.51
Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem (2006) 1.40
Autoregulation of a bacterial sigma factor explored by using segmental isotopic labeling and NMR. Proc Natl Acad Sci U S A (2002) 1.36
Bicoid cooperative DNA binding is critical for embryonic patterning in Drosophila. Proc Natl Acad Sci U S A (2005) 1.36
Malaria reemergence in northern Afghanistan. Emerg Infect Dis (2007) 1.30
Biosynthesis of a fully functional cyclotide inside living bacterial cells. Chembiochem (2007) 1.25
Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. Chembiochem (2009) 1.24
Mineralization of the metre-long biosilica structures of glass sponges is templated on hydroxylated collagen. Nat Chem (2010) 1.22
Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome. Angew Chem Int Ed Engl (2014) 1.21
Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. Eur J Biochem (2002) 1.18
Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem Biophys Res Commun (2007) 1.15
Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor. Cell Signal (2010) 1.15
Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets. BMC Biol (2010) 1.14
Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates. J Med Chem (2005) 1.13
Application of electron transfer dissociation mass spectrometry in analyses of non-enzymatically glycated peptides. Rapid Commun Mass Spectrom (2007) 1.13
A full-length group 1 bacterial sigma factor adopts a compact structure incompatible with DNA binding. Chem Biol (2008) 1.11
Automated deconvolution and deisotoping of electrospray mass spectra. J Mass Spectrom (2002) 1.11
Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. J Med Chem (2012) 1.10
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol (2011) 1.09
Backbone dynamics of cyclotide MCoTI-I free and complexed with trypsin. Angew Chem Int Ed Engl (2010) 1.07
Fragmentation behavior of glycated peptides derived from D-glucose, D-fructose and D-ribose in tandem mass spectrometry. J Mass Spectrom (2006) 1.06
Screening of small molecule interactor library by using in-cell NMR spectroscopy (SMILI-NMR). J Med Chem (2009) 1.05
Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J Biol Chem (2011) 1.04
Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug-resistant Gram-negative pathogens. ACS Chem Biol (2012) 1.04
Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. BMC Biochem (2009) 1.03
NMR study of the cataract-linked P23T mutant of human gammaD-crystallin shows minor changes in hydrophobic patches that reflect its retrograde solubility. Biochem Biophys Res Commun (2009) 1.03
The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry (2014) 1.02
In-cell NMR for protein-protein interactions (STINT-NMR). Nat Protoc (2006) 1.02
Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin. Antimicrob Agents Chemother (2012) 1.01
Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies. Mass Spectrom Rev (2013) 1.01
Spectroscopic and molecular characterization of the oligomeric antenna of the diatom Phaeodactylum tricornutum. Biochemistry (2007) 1.01
Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. J Med Chem (2010) 1.01
Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex. Chembiochem (2011) 1.00
Ion mobility separation of isomeric phosphopeptides from a protein with variant modification of adjacent residues. Anal Chem (2011) 0.99
Separation of multiphosphorylated peptide isomers by hydrophilic interaction chromatography on an aminopropyl phase. Anal Chem (2010) 0.98
Crystal structure of hexokinase KlHxk1 of Kluyveromyces lactis: a molecular basis for understanding the control of yeast hexokinase functions via covalent modification and oligomerization. J Biol Chem (2010) 0.97
In-cell biochemistry using NMR spectroscopy. PLoS One (2008) 0.97
Structural studies on the forward and reverse binding modes of peptides to the chaperone DnaK. J Mol Biol (2013) 0.94
Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice. PLoS One (2011) 0.94
Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions. Angew Chem Int Ed Engl (2013) 0.94
Disulfide bridges remain intact while native insulin converts into amyloid fibrils. PLoS One (2012) 0.94
Identification and relative quantification of specific glycation sites in human serum albumin. Anal Bioanal Chem (2010) 0.93
Segmental isotopic labeling for structural biological applications of NMR. Methods Mol Biol (2004) 0.92
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres. Eur J Nucl Med Mol Imaging (2011) 0.92
Surface supercharged human enteropeptidase light chain shows improved solubility and refolding yield. Protein Eng Des Sel (2010) 0.91
Inhibition of biofilm formation, quorum sensing and infection in Pseudomonas aeruginosa by natural products-inspired organosulfur compounds. PLoS One (2012) 0.91
Identification of cysteine, methionine and tryptophan residues of actin oxidized in vivo during oxidative stress. J Proteome Res (2010) 0.91
Easy strategy to protect antimicrobial peptides from fast degradation in serum. Antimicrob Agents Chemother (2010) 0.91
Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation. Biopolymers (2011) 0.90
Role of the interdomain linker in distance determination for remote cleavage by homing endonuclease I-TevI. J Mol Biol (2008) 0.90
Development of a pharmacologically improved peptide agonist of the leptin receptor. Biochim Biophys Acta (2008) 0.89
QCM-D fingerprinting of membrane-active peptides. Eur Biophys J (2010) 0.89
Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation. PLoS One (2010) 0.89
One RNA aptamer sequence, two structures: a collaborating pair that inhibits AMPA receptors. Nucleic Acids Res (2009) 0.89
A mutation screening platform for rapeseed (Brassica napus L.) and the detection of sinapine biosynthesis mutants. Theor Appl Genet (2011) 0.89
Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections. J Antimicrob Chemother (2010) 0.88
Simultaneous detection of low and high molecular weight carbonylated compounds derived from lipid peroxidation by electrospray ionization-tandem mass spectrometry. Anal Chem (2012) 0.88
In-cell NMR spectroscopy. Prog Nucl Magn Reson Spectrosc (2010) 0.88
Homogeneous fluorescence-based immunoassay detects antigens within 90 seconds. Anal Chem (2011) 0.88
Identification of protein carbonylation sites by two-dimensional liquid chromatography in combination with MALDI- and ESI-MS. J Proteomics (2011) 0.88
Reversible and irreversible modifications of skeletal muscle proteins in a rat model of acute oxidative stress. Biochim Biophys Acta (2009) 0.87
Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection. AIDS Res Hum Retroviruses (2009) 0.87
De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom (2010) 0.86
Mass spectrometric characterization of peptides containing different oxidized tryptophan residues. J Mass Spectrom (2011) 0.85
Carbonylated plasma proteins as potential biomarkers of obesity induced type 2 diabetes mellitus. J Proteome Res (2014) 0.85
Fragmentation behavior of Amadori-peptides obtained by non-enzymatic glycosylation of lysine residues with ADP-ribose in tandem mass spectrometry. J Mass Spectrom (2010) 0.85
Recombinant production of rhesus θ-defensin-1 (RTD-1) using a bacterial expression system. Mol Biosyst (2012) 0.85
Analysis of amadori peptides enriched by boronic acid affinity chromatography. Ann N Y Acad Sci (2008) 0.84
Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease. Biochem Biophys Res Commun (2006) 0.84
Biosynthesis and antimicrobial evaluation of backbone-cyclized α-defensins. Biochemistry (2011) 0.84
Analysis of human tau in cerebrospinal fluid. J Proteome Res (2010) 0.84
Structure of proteins in eukaryotic compartments. J Am Chem Soc (2012) 0.84
Oncocin derivative Onc72 is highly active against Escherichia coli in a systemic septicaemia infection mouse model. J Antimicrob Chemother (2012) 0.84
Protection of cats against lethal influenza H5N1 challenge infection. J Gen Virol (2008) 0.84
Blood-brain barrier transport of short proline-rich antimicrobial peptides. Protein Pept Lett (2014) 0.84
Fate of pup inside the Mycobacterium proteasome studied by in-cell NMR. PLoS One (2013) 0.83
Identification, quantification, and functional aspects of skeletal muscle protein-carbonylation in vivo during acute oxidative stress. J Proteome Res (2010) 0.83
Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens. Antimicrob Agents Chemother (2012) 0.83